Showing results (1-10 of 42) with videos related to
Sort By:
Pageof 5
Pneumologie (Stuttgart, Germany)|August 10, 2021
[Exacerbation in Idiopathic Pulmonary Fibrosis]Markus Polke, Nicolas Kahn, Michael KreuterPerfusion|May 10, 2023
Severe tracheal tear - an alternative extracorporeal membrane oxygenation indicationKatharina Buschulte, Nicolas Kahn, Werner Schmidt, et al.Respiration; International Review of Thoracic Diseases|March 6, 2010
'Heat and destroy': bronchoscopic-guided therapy of peripheral lung lesionsRalf Eberhardt, Nicolas Kahn, Felix J F HerthPresse Medicale (Paris, France : 1983)|May 22, 2020
Evolution and treatment of idiopathic pulmonary fibrosisSebastiano Emanuele Torrisi, Nicolas Kahn, Carlo Vancheri, et al.Journal of Thoracic Disease|December 20, 2017
ERS International Congress 2017: a peek of outstanding abstracts from the clinical assemblyNicolas Kahn, Vasileios Andrianopoulos, Evgeni Mekov, et al.Chest|February 16, 2010
Combined endoscopic-endobronchial ultrasound-guided fine-needle aspiration of mediastinal lymph nodes through a single bronchoscope in 150 patients with suspected lung cancerFelix J F Herth, Mark Krasnik, Nicolas Kahn, et al.European Respiratory Review : an Official Journal of the European Respiratory Society|September 6, 2019
The therapy of idiopathic pulmonary fibrosis: what is next?Vivien Somogyi, Nazia Chaudhuri, Sebastiano Emanuele Torrisi, et al.Respiratory Research|January 8, 2020
Ongoing challenges in pulmonary fibrosis and insights from the nintedanib clinical programmeClaudia Valenzuela, Sebastiano Emanuele Torrisi, Nicolas Kahn, et al.Breathe (Sheffield, England)|July 14, 2016
LSC 2016: from system approaches in lung disease to getting the job you wantAgnes Boots, Emma Flood, Nicolas Kahn, et al.Respiratory Research|August 4, 2021
Cost drivers in the pharmacological treatment of interstitial lung diseasePhillen Nozibuyiso Maqhuzu, Michael Kreuter, Thomas Bahmer, et al.Pageof 5